Johnson & Johnson delivered a beat-and-raise quarter, which is just what the doctor ordered for a breakout. Let's look at the charts of JNJ stock.
Tandem will include Abbott's Libre sensor in its insulin pump.
It's earnings season, but investors should also pay attention to tonight's debate.
The stock is cut to hold from buy as analyst David Windley sees political risk remaining for at least nine months.
Juan Ramon Alaix, CEO since 2012, is retiring. Kristin Peck currently runs U.S. operations, business development and strategy.
The medical device maker purchases Israeli laser company Eximo.
Sellers of the drugstore chain's stock have been aggressive for months and the overall technical picture is weak.
Peloton's president breaks down the path to going public and how the company plans to grow.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.